The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis.
METHODS
Systematic review and meta-analysis of randomized controlled trials and quasi-experimental studies to assess the efficacy of daily bathing with chlorhexidine (CHG) for prevention of healthcare-associated bloodstream infections (BSIs).


METHODS
Medical, surgical, trauma, and combined medical-surgical intensive care units (ICUs) and long-term acute care hospitals.


METHODS
Inpatients.


METHODS
Data on patient population, diagnostic criteria for BSIs, form and concentration of topical CHG, incidence of BSIs, and study design were extracted.


RESULTS
One randomized controlled trial and 11 nonrandomized controlled trials reporting a total of 137,392 patient-days met the inclusion criteria; 291 patients in the CHG arm developed a BSI over 67,775 patient-days, compared with 557 patients in the control arm over 69,617 catheter-days. CHG bathing resulted in a reduced incidence of BSIs: the pooled odds ratio using a random-effects model was 0.44 (95% confidence interval, 0.33-0.59; [Formula: see text]). Statistical heterogeneity was moderate, with an I(2) of 58%. For the subgroup of studies that examined central line-associated BSIs, the odds ratio was 0.40 (95% confidence interval, 0.27-0.59).


CONCLUSIONS
Daily bathing with CHG reduced the incidence of BSIs, including central line-associated BSIs, among patients in the medical ICU. Further studies are recommended to determine the optimal frequency, method of application, and concentration of CHG as well as the comparative effectiveness of this strategy relative to other preventive measures available for reducing BSIs. Future studies should also examine the efficacy of daily CHG bathing in non-ICU populations at risk for BSI.
Department of Graduate Medical Education, Aurora Healthcare Metro, Milwaukee, WI 53705, USA.
John C
JC
O'Horo
Germana L M
GL
Silva
L Silvia
LS
Munoz-Price
Nasia
N
Safdar
D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D001494:Baths / Q000379:methods*; D002408:Catheters, Indwelling / Q000009:adverse effects; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use*; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control*; D004866:Equipment Contamination; D006748:Hospital Departments; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007362:Intensive Care Units; D016032:Randomized Controlled Trials as Topic; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*
D000891:Anti-Infective Agents, Local; D002710:Chlorhexidine